Free Newsletter
SPOTLIGHT: FDA warns J&J unit on heart drug marketing
Free newsletter via e-mail
Tools
Promotional pens and mouse pads landed a Johnson & Johnson unit it hot water with the FDA. The tchotchkes, which featured the heart drug Natrecor, didn't include warnings about its "numerous risks," the agency said. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: